BioMarin Pharmaceutical's total assets for Q2 2024 were $7.07B, an increase of 2.83% from the previous quarter. DE:BM8 total liabilities were $1.78B for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.